查詢結果分析
來源資料
頁籤選單縮合
題 名 | 突發性耳聾藥物治療=The Treatment of Sudden Sensorineural Hearing Loss |
---|---|
作 者 | 陳昱旻; 郭正睿; 童玟津; 簡素玉; | 書刊名 | 藥學雜誌 |
卷 期 | 28:2=111 2012.06[民101.06] |
頁 次 | 頁69-73 |
分類號 | 416.865 |
關鍵詞 | 突發性耳聾; 類固醇; 利尿劑; Sudden sensorineural hearing loss; Steroids; Diuretics; |
語 文 | 中文(Chinese) |
中文摘要 | 突發性耳聾 (sudden sensorineural hearing loss , SSNHL),又俗稱耳中風,其定義為72小時之內出現連續3個頻率大於30分貝的感音神經性聽力損失。SSNHL 的真正病因不明,許多可能之致病機轉被提出,包括感染、耳毒性藥物、腫瘤、創傷、自體免疫、微血管疾病或其他因素,通常很難確定其致病因,造成 SSNHL 的最常見的原因可能是血管因素導致之組織缺血或病毒感染導致之神經炎。 目前尚無針對 SSNHL 之有效治療選擇,治療效果具有許多不確定性,缺乏完整的有效之治療規範,故多採用合併式療法。建議治療藥品包括口服類固醇、血管擴張劑、改善耳流力藥物、抗病毒藥物、利尿劑等。 突發性耳聾大多有良好的預後,年齡愈大,復原或治療效果愈差;聽力喪失愈嚴重,極重度重聽的患者預後不良,高頻率聽力喪失者比低頻率之預後差;合併有眩暈者之預後差;愈早接受類固醇治療者,預後愈好。 |
英文摘要 | Sudden deafness (sudden sensorineural hearing loss, SSNHL), also commonly known as ear stroke, defined as idiopathic hearing loss of at least 30 dB over three test frequencies occurring within 72 hours.The etiology of most cases of sudden sensorineural hearing loss (SSNHL) is uncertain, postulated causes for idiopathic SSNHL include viral cochleitis, microvascular events , autoimmune disorders, ototoxic drugs, cancer, trauma, or other factors, often difficult to determine, the most common cause SSNHL may be due to vascular factors leading to the result of ischemia or viral infection of neuritis. Strong evidence for the efficacy of any treatment option for patients with SSNHL is not available. Management strategies vary, reflecting the uncertainty of treatment efficacy, absence of society guidelines, and significant rate of spontaneous recovery. Empiric therapy is combination of various drug. The recommended drugs, including steroids, vasodilators, improving cochlear blood flow, antiviral drugs, diuretics, etc. The prognosis for most of SSNHL is good, especially if it is a low frequency hearing loss pattern, and earlier steroid treatment. The prognosis is poor in patients associated with vertigo, elder and very severe hearing loss. |
本系統中英文摘要資訊取自各篇刊載內容。